Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Eμ-c-myc or N-myc transgenes

International Journal of Cancer

Volumn 88, Issue 6, 2000, Pages 920-927

  Linardopoulos, Spiros ^a   Silva, Santiago ^b   Klein, George ^b   Balmain, Allan ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 9; CHROMOSOME MARKER; FEMALE; GENETIC RECOMBINATION; HETEROZYGOSITY LOSS; MALE; MOUSE; NONHUMAN; ONCOGENE C MYB; ONCOGENE C MYC; PLASMACYTOMA; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0034672287     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001215)88:6<920::aid-ijc13>3.0.co;2-%23     Document Type: Article

References (35)

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
2. Ataxia telangiectasia mutant protein activates c-abl tyrosine kinase in response to ionizing radiation
3. The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53
4. The laboratory mouse and its wild relatives
5. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7
6. mdm-2 Inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein
7. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3HF1 mouse
8. IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: Generation of lymphoid neoplasias that lack c-myc expression
9. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity
10. Extraction of nucleic acid from fresh and archival materials
11. Allelotype analysis of mouse skin tumors using polymorphic microsatellites: Sequential genetic alterations on chromosomes 6, 7 and 11
12. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
13. Deletion and altered regulation of p16(INK4a) and p15(INK4b) in undifferentiated mouse skin tumors
14. Amplified chromosomal elements containing c-Myc and Pvt-1 in a mouse plasmacytoma
15. Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses
16. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
17. The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4
18. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis
19. Distinct genetic loci control development of benign and malignant skin tumours in mice
20. Tumor suppressor loci on mouse chromosome 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma
21. A novel 6:10 chromosomal translocation in murine plasmacytoma NS-1
22. Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice
23. N-myc transgene promotes B-lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc
24. Multiple mechanisms of p16(INK4A) inactivation in non-small cell lung cancer cell lines
25. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras
26. An exceptional mouse plasmacytoma with a new kappa/N-myc [T(6; 12)(C1;B)] translocation expresses N-myc but not c-myc
27. Abelson murine leukemia virus transforms preneoplastic Eu-myc transgene carrying cells of the B-lymphocyte lineage into plasmablastic tumors
28. Gene interaction and single gene effects in colon tumour susceptibility in mice
29. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: Plasmacytoma development in N-myc transgenic mice
30. A rapid method for preparing DNA from blood, suited for PCR screening of transgenes in mice
31. Triplication of one chromosome no. 15 with an altered c-myc containing EcoRI fragment and elimination of the normal homologue in a T-cell lymphoma line of AKR origin (TIKAUT)
32. The role of p16(INK4a) (Cdkn2a) in mouse plasma cell tumors
33. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16(INK4a) and p19(ARF), is a candidate for the plasmacytoma susceptibility locus, Pctr1
34. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice